Download video

Brentuximab for second-line lymphoma treatment

179 views

VJHemOnc – Video Journal of Hematology & HemOnc

6 years ago

Brentuximab for second-line lymphoma treatment

Brentuximab for second-line lymphoma treatment

Brentuximab for second-line lymphoma treatment
2:31
Brentuximab for second-line lymphoma treatment
by VJHemOnc – Video Journal of Hematology \& HemOnc
ECHELON-2: brentuximab vedotin and CHP for CD30-positive T-cell lymphomas
1:32
ECHELON-2: brentuximab vedotin and CHP for CD30-positive T-cell lymphomas
by VJHemOnc – Video Journal of Hematology \& HemOnc
Phase II study of brentuximab vedotin + CHP in patients with PTCL with less than 10% CD30 expression
3:48
Phase II study of brentuximab vedotin + CHP in patients with PTCL with less than 10% CD30 expression
by VJHemOnc – Video Journal of Hematology \& HemOnc
Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - Brentuximab
15:15
Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - Brentuximab
by HMP Education
Brentuximab vedotin plus ICE as a second line treatment in R\/R Hodgkin lymphoma
1:27
Brentuximab vedotin plus ICE as a second line treatment in R\/R Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximib vedotin therapy for Hodgkin lymphoma
2:18
Brentuximib vedotin therapy for Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. Flinn on FDA Approval of Frontline Brentuximab Vedotin With AVD in Hodgkin Lymphoma
0:57
Dr. Flinn on FDA Approval of Frontline Brentuximab Vedotin With AVD in Hodgkin Lymphoma
by OncLive
Brentuximab vedotin combined with nivolumab for Hodgkin lymphoma
1:14
Brentuximab vedotin combined with nivolumab for Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximab vedotin for CTCL
2:30
Brentuximab vedotin for CTCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximab Vedotin in CD30-Positive Lymphoma
6:57
Brentuximab Vedotin in CD30-Positive Lymphoma
by OncLive
Updates on the use of brentuximab vedotin in later-stage HL
1:04
Updates on the use of brentuximab vedotin in later-stage HL
by VJHemOnc – Video Journal of Hematology \& HemOnc
A Study of Brentuximab Vedotin and Nivolumab in Relapsed or Treatment-Resistant Hodgkin Lymphoma
0:51
A Study of Brentuximab Vedotin and Nivolumab in Relapsed or Treatment-Resistant Hodgkin Lymphoma
by Targeted Oncology
Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma
5:59
Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma
by ecancer
Advantages of Brentuximab Vedotin and Chemotherapy Combination for Advanced Stage Hodgkin Lymphoma
0:57
Advantages of Brentuximab Vedotin and Chemotherapy Combination for Advanced Stage Hodgkin Lymphoma
by Rare Disease Report
A Study Examining Brentuximab Vedotin in Patients With High-Risk Large B-Cell Lymphoma
2:51
A Study Examining Brentuximab Vedotin in Patients With High-Risk Large B-Cell Lymphoma
by Targeted Oncology
Dr. Diehl Discusses Brentuximab Vedotin
1:52
Dr. Diehl Discusses Brentuximab Vedotin
by OncLive
Brentuximab vedotin, nivolumab, doxorubicin \& dacarbazine for early stage classical Hodgkin lymphoma
3:23
Brentuximab vedotin, nivolumab, doxorubicin \& dacarbazine for early stage classical Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Nivolumab and brentuximab vedotin with or without bendamustine for R\/R Hodgkin lymphoma
1:08
Nivolumab and brentuximab vedotin with or without bendamustine for R\/R Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Debate: Brentuximab vedotin as upfront therapy for advanced Hodgkin lymphoma? - Yes
11:21
Debate: Brentuximab vedotin as upfront therapy for advanced Hodgkin lymphoma? - Yes
by HMP Education
Brentuximab vedotin and CHP for PTCL: upcoming Phase II trial
2:44
Brentuximab vedotin and CHP for PTCL: upcoming Phase II trial
by VJHemOnc – Video Journal of Hematology \& HemOnc